Tags : BNT162

Biotech COVID-19

Pfizer and BioNTech Collaborate to Co-Develop BNT162 Against COVID-19

Shots: The companies collaborate to accelerate the development of BioNTech’s BNT162, which is anticipated to enter clinical studies by the end of Apr’2020. The alliance will leverage the expertise and resources of both companies to co-develop mRNA-based vaccine candidate globally (Ex- China) The collaboration follows 2018 agreement signed b/w the companies to develop mRNA-based vaccines […]Read More